Breast Implant Safety — Facts & Research

The Overall Safety Picture

Breast implants have one of the most extensively studied safety profiles of any medical device — they have been in use for over 60 years and have been the subject of thousands of clinical studies. The overall conclusion of the scientific literature is that modern breast implants do not cause systemic disease, cancer, or autoimmune conditions at rates above background population levels. They do carry specific local risks (capsular contracture, rupture, malposition) that are well-documented and manageable. They are not permanent devices and most patients will require at least one additional surgery over a lifetime.

Silicone Safety: The Historical Controversy

In the 1990s, concerns arose that silicone gel implants might cause connective tissue diseases and autoimmune conditions. This led the FDA to restrict silicone gel use for cosmetic augmentation from 1992–2006. Subsequent large-scale epidemiological studies — including several involving hundreds of thousands of women — found no statistically significant association between silicone implants and systemic disease. The FDA reapproved silicone gel implants for augmentation in 2006 based on this evidence.

BIA-ALCL: The Real Risk

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a rare type of lymphoma that develops in the scar tissue around breast implants. It is not breast cancer — it is a lymphoma of the scar tissue. It is associated specifically with textured implants rather than smooth implants. The cumulative risk is estimated at approximately 1 in 2,000–10,000 for textured implant patients (estimates vary by study). It is typically detected as swelling or fluid around an implant and is highly treatable when caught early — treatment usually involves implant and capsule removal. Most cases resolve with surgery alone.

Breast Implant Illness (BII)

Breast Implant Illness is a term used by some patients to describe a constellation of symptoms they attribute to their implants — fatigue, brain fog, joint pain, and various other systemic symptoms. While the experiences of these patients are real and should be taken seriously, the scientific evidence for a causal relationship between implants and these symptoms remains inconclusive. Some patients report significant symptom improvement after explant surgery (implant removal); controlled studies have not yet definitively established causation. If you are experiencing unexplained systemic symptoms, discussing them with your surgeon and considering explant if symptoms are significantly affecting quality of life is reasonable.